Welcome back to Stockhouse Member Sign In
Send my password
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
While patent news produced a healthy gain for a medical diagnostic stock Monday
John Kaiser's assessment of the PEA was positive; he described Nyngan's economics as "robust" and superior to his original April 2014...
Has anyone seen a comment by Kaiser on the PEA? I'm interested in what he had to say.
It would get back to this level. ANON as usual spoiling the party. With an NPV like this though its a short term hold back....
wow....missed the news yesterday but saw it last night. I was lucky to buy in this morning at .115 The conservative estimates should...